Ahmad Z. Bahlool, Sarinj Fattah, Andrew O'Sullivan, Brenton Cavanagh, Ronan MacLoughlin, Joseph Keane, . . . Sally-Ann Cryan. (2022). Development of Inhalable ATRA-Loaded PLGA Nanoparticles as Host-Directed Immunotherapy against Tuberculosis. MDPI AG.
Chicago Style (17th ed.) CitationAhmad Z. Bahlool, Sarinj Fattah, Andrew O'Sullivan, Brenton Cavanagh, Ronan MacLoughlin, Joseph Keane, Mary P. O'Sullivan, and Sally-Ann Cryan. Development of Inhalable ATRA-Loaded PLGA Nanoparticles as Host-Directed Immunotherapy Against Tuberculosis. MDPI AG, 2022.
MLA (9th ed.) CitationAhmad Z. Bahlool, et al. Development of Inhalable ATRA-Loaded PLGA Nanoparticles as Host-Directed Immunotherapy Against Tuberculosis. MDPI AG, 2022.
Warning: These citations may not always be 100% accurate.